首页> 美国卫生研究院文献>other >P Wave Dispersion and Maximum P Wave Duration Are Independently Associated with Rapid Renal Function Decline
【2h】

P Wave Dispersion and Maximum P Wave Duration Are Independently Associated with Rapid Renal Function Decline

机译:p波离散和最大p波时限独立地被快速肾功能下降有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The P wave parameters measured by 12-lead electrocardiogram (ECG) are commonly used as noninvasive tools to assess for left atrial enlargement. There are limited studies to evaluate whether P wave parameters are independently associated with decline in renal function. Accordingly, the aim of this study is to assess whether P wave parameters are independently associated with progression to renal end point of ≥25% decline in estimated glomerular filtration rate (eGFR). This longitudinal study included 166 patients. The renal end point was defined as ≥25% decline in eGFR. We measured two ECG P wave parameters corrected by heart rate, i.e. corrected P wave dispersion (PWdisperC) and corrected P wave maximum duration (PWdurMaxC). Heart function and structure were measured from echocardiography. Clinical data, P wave parameters, and echocardiographic measurements were compared and analyzed. Forty-three patients (25.9%) reached renal end point. Kaplan-Meier curves for renal end point-free survival showed PWdisperC > median (63.0 ms) (log-rank P = 0.004) and PWdurMaxC > median (117.9 ms) (log-rank P<0.001) were associated with progression to renal end point. Multivariate forward Cox-regression analysis identified increased PWdisperC (hazard ratio [HR], 1.024; P = 0.001) and PWdurMaxC (HR, 1.029; P = 0.001) were independently associated with progression to renal end point. Our results demonstrate that increased PWdisperC and PWdurMaxC were independently associated with progression to renal end point. Screening patients by means of PWdisperC and PWdurMaxC on 12 lead ECG may help identify a high risk group of rapid renal function decline.
机译:由12导联心电图(ECG)测量的P波参数通常用作评估左心房扩大的非侵入性工具。评估P波参数是否与肾功能下降独立相关的研究有限。因此,本研究的目的是评估P波参数是否与肾小球滤过率(eGFR)下降≥25%的肾终点进展相关。这项纵向研究包括166例患者。肾终点定义为eGFR下降≥25%。我们测量了通过心率校正的两个ECG P波参数,即校正的P波离散度(PWdisperC)和校正的P波最大持续时间(PWdurMaxC)。通过超声心动图测量心脏功能和结构。比较并分析了临床数据,P波参数和超声心动图测量结果。四十三名患者(25.9%)达到了肾脏终点。肾终点无生存期的Kaplan-Meier曲线显示PWdisperC>中位数(63.0 ms)(log-rank P = 0.004)和PWdurMaxC>中位数(117.9 ms)(log-rank P <0.001)与肾末进展有关点。多元正向Cox回归分析确定PWdisperC(危险比[HR],1.024; P = 0.001)和PWdurMaxC(HR,1.029; P = 0.001)升高与肾终点进展相关。我们的结果表明,增加的PWdisperC和PWdurMaxC与肾脏进展相关。通过12导联心电图上的PW分散C和PWdurMaxC筛查患者可能有助于确定肾功能快速下降的高危人群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号